MetLife Investment Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Sell |
10,520
-77
| -0.7% | -$3.24K | ﹤0.01% | 1736 |
|
|
2025
Q1 | $401K | Sell |
10,597
-78
| -0.7% | -$2.95K | ﹤0.01% | 1824 |
|
|
2024
Q4 | $822K | Buy |
10,675
+544
| +5% | +$41.9K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $583K | Buy |
10,131
+5,708
| +129% | +$328K | ﹤0.01% | 1699 |
|
|
2024
Q2 | $183K | Buy |
+4,423
| New | +$183K | ﹤0.01% | 2309 |
|
|
2022
Q2 | – | Sell |
-1,296
| Closed | -$198K | – | 2896 |
|
|
2022
Q1 | $198K | Buy |
1,296
+423
| +48% | +$64.8K | ﹤0.01% | 2358 |
|
|
2021
Q4 | $258K | Buy |
873
+150
| +21% | +$44.3K | ﹤0.01% | 1896 |
|
|
2021
Q3 | $200K | Hold |
723
| – | – | ﹤0.01% | 2101 |
|
|
2021
Q2 | $198K | Buy |
723
+377
| +109% | +$103K | ﹤0.01% | 2181 |
|
|
2021
Q1 | $170K | Hold |
346
| – | – | ﹤0.01% | 2139 |
|
|
2020
Q4 | $286K | Buy |
+346
| New | +$286K | ﹤0.01% | 1792 |
|